Logo image of ZYBT

ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) Stock Price, Quote, News and Overview

NASDAQ:ZYBT - Nasdaq - KYG989MS1016 - Common Stock - Currency: USD

7.51  -0.1 (-1.31%)

ZYBT Quote, Performance and Key Statistics

ZHENGYE BIOTECHNOLOGY HOLDIN

NASDAQ:ZYBT (8/15/2025, 8:00:02 PM)

7.51

-0.1 (-1.31%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap355.90M
Shares47.39M
Float4.17M
Yearly Dividend0.05
Dividend YieldN/A
PE62.58
Fwd PEN/A
Earnings (Next)N/A N/A
IPO01-07 2025-01-07


ZYBT short term performance overview.The bars show the price performance of ZYBT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30 40 50

ZYBT long term performance overview.The bars show the price performance of ZYBT in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ZYBT is 7.51 USD. In the past month the price increased by 31.99%.

ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT Daily stock chart

ZYBT Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 43.42 664.58B
JNJ JOHNSON & JOHNSON 17.66 425.41B
AZN ASTRAZENECA PLC-SPONS ADR 17.83 245.46B
NVS NOVARTIS AG-SPONSORED ADR 14.04 240.45B
NVO NOVO-NORDISK A/S-SPONS ADR 13.4 232.88B
MRK MERCK & CO. INC. 10.94 211.45B
PFE PFIZER INC 7.42 142.93B
SNY SANOFI-ADR 11.21 121.39B
BMY BRISTOL-MYERS SQUIBB CO 7.2 98.58B
GSK GSK PLC-SPON ADR 8.61 79.42B
ZTS ZOETIS INC 24.78 68.61B
TAK TAKEDA PHARMACEUTIC-SP ADR 50 47.37B

About ZYBT

Company Profile

ZYBT logo image Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 275 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.

Company Info

ZHENGYE BIOTECHNOLOGY HOLDIN

No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone

Jilin JILIN CN

Employees: 275

ZYBT Company Website

ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT FAQ

What is the stock price of ZHENGYE BIOTECHNOLOGY HOLDIN today?

The current stock price of ZYBT is 7.51 USD. The price decreased by -1.31% in the last trading session.


What is the ticker symbol for ZHENGYE BIOTECHNOLOGY HOLDIN stock?

The exchange symbol of ZHENGYE BIOTECHNOLOGY HOLDIN is ZYBT and it is listed on the Nasdaq exchange.


On which exchange is ZYBT stock listed?

ZYBT stock is listed on the Nasdaq exchange.


What is ZHENGYE BIOTECHNOLOGY HOLDIN worth?

ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) has a market capitalization of 355.90M USD. This makes ZYBT a Small Cap stock.


How many employees does ZHENGYE BIOTECHNOLOGY HOLDIN have?

ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) currently has 275 employees.


What are the support and resistance levels for ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) stock?

ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) has a support level at 5.3 and a resistance level at 8.41. Check the full technical report for a detailed analysis of ZYBT support and resistance levels.


Should I buy ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) stock pay dividends?

ZYBT does not pay a dividend.


What is the Price/Earnings (PE) ratio of ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT)?

The PE ratio for ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) is 62.58. This is based on the reported non-GAAP earnings per share of 0.12 and the current share price of 7.51 USD. Check the full fundamental report for a full analysis of the valuation metrics for ZYBT.


What is the Short Interest ratio of ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) stock?

The outstanding short interest for ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) is 5.91% of its float. Check the ownership tab for more information on the ZYBT short interest.


ZYBT Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ZYBT.


Chartmill TA Rating
Chartmill Setup Rating

ZYBT Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ZYBT. Both the profitability and the financial health of ZYBT get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZYBT Financial Highlights

Over the last trailing twelve months ZYBT reported a non-GAAP Earnings per Share(EPS) of 0.12. The EPS increased by 21.94% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.95%
ROA 7.96%
ROE 13.83%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%-64.04%
Sales Q2Q%-11.95%
EPS 1Y (TTM)21.94%
Revenue 1Y (TTM)43.18%

ZYBT Ownership and Analysts


Ownership
Inst Owners0.1%
Ins Owners6.53%
Short Float %5.91%
Short Ratio0.67
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A